Notes from the Field: Effectiveness of Prevention and Control Measures for Imported COVID-19 in Guangming District of Shenzhen

Abstract

Novel coronavirus disease 2019 (COVID-19) was present in most provinces of China after January 2020. We implemented a surveillance and screening strategy that included early detection of laboratory-confirmed COVID-19 cases and people who were exposed to the disease in Guangming District of Shenzhen. Separate targeted treatment and management strategies were applied to confirmed and suspected cases. From January 23 to March 13, 2020, we found 12 suspected cases, and 11 were confirmed as positive. Although eight of the 11 confirmed cases were family-aggregated, they were all imported cases with common exposure, which did not further cause local community transmission, and no medical staff were infected. After February 14, when the last case was confirmed, there were no newly confirmed cases for 28 consecutive days under the strict outbreak control. The targeted and whole-society involved prevention and control measures prevented the spread of the disease in a very short time and provided a strong guarantee for the orderly recovery of returning to work and social activities.

Keywords

COVID-19 epidemic prevention and control measures effective evaluation resumption of work and production

Get full access to this article

View all access options for this article.

References

Adhikari

S. P.

Meng

Y. J.

Mao

Y. P.

R. X.

Wang

Q. Z.

Sun

Sylvia

Rozelle

Raat

Zhou

(2020). Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: A scoping review. Infectious Diseases of Poverty, 9(1), 29. https://doi.org/10.1186/s40249-020-00646-x

Chan

J. F.

Kok

K. H.

Zhu

Chu

K. K.

Yuan

Yuen

K. Y.

(2020). Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging Microbes & Infections, 9(1), 221–236. https://doi.org/10.1080/22221751.2020.1719902

Chen

Liu

Guo

(2020). Emerging coronaviruses: Genome structure, replication, and pathogenesis. Journal of Medical Virology, 92(4), 418–423. https://doi.org/10.1002/jmv.25681

Corman

V. M.

Landt

Kaiser

Molenkamp

Meijer

Chu

D. K. W.

Bleicker

Brünink

Schneider

Schmidt

M. L.

Mulders

D. G.

Haagmans

B. L.

van der Veer

van den Brink

Wijsman

Goderski

Romette

J.-L.

Ellis

Zambon

Drosten

(2020). Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance, 25(3). https://doi.org/10.2807/1560-7917.ES.2020.25.3.2000045

Dhama

Sharun

Tiwari

Dadar

Malik

Y. S.

Singh

K. P.

Chaicumpa

(2020). COVID-19, an emerging coronavirus infection: Advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Human Vaccines & Immunotherapeutics, 16(6), 1232–1238. https://doi.org/10.1080/21645515.2020.1735227

Huang

Wang

Ren

Zhao

Zhang

Fan

Cheng

Xia

Wei

Xie

Yin

Liu

Cao

(2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223), 497–506. https://doi.org/10.1016/S0140-6736(20)30183-5

Guan

Wang

Zhou

Tong

Ren

Leung

K. S. M.

Lau

E. H. Y.

Wong

J. Y.

Xing

Xiang

Chen

Liu

Zhao

Liu

Feng

(2020). Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. The New England Journal of Medicine, 382(13), 1199–1207. https://doi.org/10.1056/NEJMoa2001316

Liu

R. S.

Z. Q.

(2020). Challenges to prevent and control the outbreak of novel coronavirus pneumonia (COVID-19). Zhonghua Liu Xing Bing Xue Za Zhi, 41(0), E029. https://doi.org/10.3760/cma.j.cn112338-20200216-00108

Pang

Wang

M. X.

Ang

I. Y. H.

Tan

S. H. X.

Lewis

R. F.

Chen

J. I.

Gutierrez

R. A.

Gwee

S. X. W.

Ee Yong Chua

Yang

X. Y.

Yap

R. K. S.

Tan

H. Y.

Teo

Y. Y.

Tan

C. C.

Cook

A. R.

Yap

J. C.-H.

Hsu

L. Y.

(2020). Potential rapid diagnostics, vaccine and therapeutics for 2019 novel coronavirus (2019-nCoV): A systematic review. Journal of Clinical Medicine, 9(3). https://doi.org/10.3390/jcm9030623

10.

Riou

Althaus

C. L.

(2020). Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Euro Surveill, 25(4). https://doi.org/10.2807/1560-7917.ES.2020.25.4.2000058

11.

Zhao

Chen

Y. M.

Wang

Song

Z. G.

Tao

Z. W.

Tian

J.-H.

Pei

Y.-Y.

Yuan

M.-L.

Zhang

Y.-L.

Dai

F.-H.

Liu

Wang

Q.-M.

Zheng

J.-J.

Holmes

E. C.

Zhang

Y. Z.

(2020). A new coronavirus associated with human respiratory disease in China. Nature, 579(7798), 265–269. https://doi.org/10.1038/s41586-020-2008-3

12.

X. W.

X. X.

Jiang

X. G.

K. J.

Ying

L. J.

C. L.

S.-B.

Wang

H.-Y.

Zhang

Gao

H.-N.

Sheng

J.-F.

Cai

H.-L.

Qiu

Y.-Q.

L. J.

(2020). Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: Retrospective case series. British Medical Journal, 368, m606. https://doi.org/10.1136/bmj.m606

13.

Yuen

K. S.

Z. W.

Fung

S. Y.

Chan

C. P.

Jin

D. Y.

(2020). SARS-CoV-2 and COVID-19: The most important research questions. Cell & Bioscience, 10, 40. https://doi.org/10.1186/s13578-020-00404-4

14.

Zhu

Zhang

Wang

Yang

Song

Zhao

Huang

Shi

Niu

Zhan

Wang

Gao

G. F.

Tan

Research

(2020). A novel coronavirus from patients with pneumonia in china, 2019. The New England Journal of Medicine, 382(8), 727–733. https://doi.org/10.1056/NEJMoa2001017